Thurston Springer Miller Herd & Titak’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$580 Hold
28
﹤0.01% 1193
2026
Q1
$652 Hold
28
﹤0.01% 1275
2025
Q4
$1.24K Buy
+28
New +$1.57K ﹤0.01% 1273
2025
Q3
Sell
-28
Closed -$1.72K 750
2025
Q2
$1.72K Hold
28
﹤0.01% 1441
2025
Q1
$1.62K Hold
28
﹤0.01% 1468
2024
Q4
$1.49K Hold
28
﹤0.01% 1165
2024
Q3
$1.22K Hold
28
﹤0.01% 1385
2024
Q2
$783 Buy
+28
New +$739 ﹤0.01% 1420

Other funds holding DOCS

Thurston Springer Miller Herd & Titak's DOCS Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak held its Doximity (DOCS) position steady in Q2 2026 at 28 shares worth $580. The position accounts for ﹤0.01% of the portfolio, ranked #1193.

Thurston Springer Miller Herd & Titak first reported a position in DOCS in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.72K in Q2 2025. 74 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 28 shares of Doximity worth $580 as of Q2 2026.
  • Thurston Springer Miller Herd & Titak left its Doximity share count unchanged in Q2 2026.
  • Doximity made up ﹤0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #1193 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in Doximity in Q2 2024 and has held it in 8 quarters since.
  • Thurston Springer Miller Herd & Titak's Doximity position peaked at $1.72K in Q2 2025.
  • 74 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.